Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-035211
Filing Date
2025-02-25
Accepted
2025-02-25 16:42:05
Documents
15
Effectiveness Date
2025-02-25

Document Format Files

Seq Description Document Type Size
1 S-8 d916489ds8.htm S-8 51291
2 EX-5.1 d916489dex51.htm EX-5.1 22902
3 EX-23.1 d916489dex231.htm EX-23.1 2640
4 EX-FILING FEES d916489dexfilingfees.htm   iXBRL EX-FILING FEES 25442
  Complete submission text file 0001193125-25-035211.txt   237414

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d916489dexfilingfees_htm.xml XML 7328
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285216 | Film No.: 25664205
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)